DataMEDS AI operates in the healthcare technology sector, combining pharmacy services, telemedicine, and pharmaceutical distribution with artificial intelligence platforms. The company develops software tools for pharmacy operations and medication adherence, while also offering clinical support services and oncology-focused precision medicine solutions. Based in Tampa, Florida, DataMEDS AI integrates multiple healthcare business lines to serve physicians and patients across various medical specialties.
1Y: 4.64 (-93.3%) · range 0.85–69.00
entry readiness 40 · WEAK SETUP · exit proximity 53
Value area 0.82–8.63 · 52% of 120d volume overhead · heavy supply
MEDS reads as a coin-flip on a thin, single-family dossier: the only contributing source in 21 days is Retail Forum Chatter (1.000), and both scoring systems land in the middle (blend 47/100, absolute 48/100 HOLD/NEUTRAL). The daily lane explicitly PASSes with readiness 40 and no setup, and there is no Monte Carlo on record — so there is no promoted, orthogonal evidence to convict on in either direction.
- Absolute score 48/100 with an explicit HOLD/NEUTRAL signal and MeanRev regime — squarely neutral
- Markov trend UP with P(stay) 78% offers modest constructive tape support
- Buildup leg is elevated at 70, hinting at second-order acceleration under the surface
- Daily lane is PASS (MID-BULL, readiness 40 — 'too early/late; no setup'), size 0.0% — Orca's own mechanics decline the name
- Only one contributing source (Retail Forum Chatter 1.000), a low-quality narrative family with zero orthogonal confirmation
- VScore just 22 and EMA/technical 40 undercut the elevated Buildup leg; pattern and peer-cluster overlays both NEUTRAL (score 0)
- No pre-trade Monte Carlo on record — the risk distribution is unquantified
Invalidated if: A hard evidence family firing (insider cluster, earnings surprise at the 2026-08-17 print, or a lane flip from PASS to OPEN) would break the neutral read; conversely a Markov flip out of UP would confirm downside.
| Source | Score | Last seen |
|---|---|---|
| forum-chatter | 1.000 | Sep 17, 2026 |
Not yet labeled — the study prices these as positions mature.